Cell-based passive immunization for protection against SARS-CoV-2 infection

BACKGROUND: Immunologically impaired individuals respond poorly to vaccines, highlighting the need for additional strategies to protect these vulnerable populations from COVID-19. While monoclonal antibodies (mAbs) have emerged as promising tools to manage infectious diseases, the transient lifespan...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawula, Evan, Miersch, Shane, Jong, Eric D., Li, Chengjin, Chou, Fang-Yu, Tang, Jean Kit, Saberianfar, Reza, Harding, Jeffrey, Sidhu, Sachdev S., Nagy, Andras
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629160/
https://www.ncbi.nlm.nih.gov/pubmed/37932852
http://dx.doi.org/10.1186/s13287-023-03556-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629160/
https://www.ncbi.nlm.nih.gov/pubmed/37932852
http://dx.doi.org/10.1186/s13287-023-03556-5

Ejemplares similares